Oversimplifies trends and ignores real-world disruptions. Can’t predict economic downturns, competitor actions and shifts in customer behavior on its own. Ignores randomness; every forecast will have ...
Following Priority Review, the U.S. FDA granted HYRNUO® (sevabertinib) approval for the treatment of adult patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) ...
DESTINY-Lung06 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic Non-Squamous Non-Small Cell Lung Cancer The first patient has been dosed in the ...
Pixel 10 devices are being affected by a screen glitch. The glitch covers the screen in static-like snow. For now, Google is investigating, but there's no fix. The Google Pixel 10 series has only been ...
XTANDI: the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in non-metastatic hormone-sensitive prostate cancer (nmHSPC) with high-risk biochemical ...
Four days ahead of its July 7 PDUFA date, the U.S. FDA granted accelerated approval to Dizal (Jiangsu) Pharmaceutical Co. Ltd.’s sunvozertinib (DZD-9008), branded as Zegfrovy, for treating adults with ...
Abstract: Numerical analysis of static field problems is often encountered in science and engineering. The boundary element methods based on integral equations are popular due to small number of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback